Immune B-cells that contain the receptor protein CD226 may play a role in the development and clinical manifestations of primary Sjögren’s disease, making CD226 a possible target for future treatments, a study reports. Data indicated that people with Sjögren’s had proportionally more CD226-positive B-cells in their bloodstream than their healthy counterparts. The prevalence of these […] The post B-cells containing CD226 may be Sjögren’s biomarker, therapy target appeared first on S...| Sjogren's Disease News – The Web's Daily Resource for Sjogren's Disease News
Levels of the molecule S1P in Cushing's were found to help identify pituitary gland tumor location and to predict remission after surgery.| Cushing's Disease News
This newest Critical Path Institute® (C-Path) podcast episode provides an in-depth exploration of one of C-Path's core teams...| C-Path
The brain’s electrical activity in response to sound may serve as a biomarker for Rett treatment response, per a study.| Rett Syndrome News
Blood levels of anti-AQP5 antibodies may be used as a biomarker to diagnose primary Sjögren’s disease, according to a new study from China.| Sjogren's Syndrome News
In a study, low TTR blood levels correlated with higher markers of inflammation, low BMI, and higher primary Sjögren's disease activity.| Sjogren's Syndrome News
Levels of GFAP in cerebrospinal fluid (CSF) may be a marker of Huntington’s disease progression, a study found.| Huntington's Disease News
A U.S. study shows that repeated sampling of hair follicles in people with fragile X syndrome can be used to measure FMRP protein levels.| Fragile X News Today
A photo-detection method can measure lactoferrin in dry eye disease patients' tears, making it a possible biomarker of disease severity.| Sjogren's Syndrome News
Primary Sjögren’s patients with extra-glandular symptoms have higher CXCL9 levels than those whose disease affects the saliva and tear glands.| Sjogren's Syndrome News